Inventor
Konrad Feichtinger
Inventor
San Diego, CA, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
Y02ATechnologies for adaptation to climate change12%
C07CAcyclic or carbocyclic compounds3%
C07KPeptides3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
PatentTitleYear
10,781,1803-phenyl-pyrazole derivatives as modulators of the 5-HT202010,624,9005-HT202010,450,276Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto201910,272,0945-HT2C receptor agonists and compositions and methods of use201910,058,549Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT20189,987,252Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto20189,567,327'Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20179,328,107'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20169,221,755'Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'2015RE045336'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'2015RE045337'Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20158,785,441'3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20148,680,119'Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20148,664,258'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20148,148,418'Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20128,148,417'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20127,884,101'3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20116,380,358'Guanidinylation reagents'20026,072,075'Guanidinylation reagents'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2020Based in San Diego, CA, US· patent location history
2011–2020Patents assigned to ARENA PHARM INC (17)· patent assignee history
2012–2017Patents assigned to FEICHTINGER KONRAD (6)· patent assignee history
2012–2014Patents assigned to JAYAKUMAR HONNAPPA (5)· patent assignee history
2012–2014Patents assigned to TEEGARDEN BRADLEY (5)· patent assignee history
2012–2014Patents assigned to CHAPMAN DENNIS (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARENA PHARM INC | 17 | 2011–2020 |
| FEICHTINGER KONRADself | 6 | 2012–2017 |
| JAYAKUMAR HONNAPPA | 5 | 2012–2014 |
| TEEGARDEN BRADLEY | 5 | 2012–2014 |
| CHAPMAN DENNIS | 4 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 19 | 2000–2020 |